Pilot Study and Review: Physiological Differences in BDNF, a Potential Biomarker in Males and Females with Autistic Disorder
Journal Title: International Neuropsychiatric Disease Journal - Year 2015, Vol 3, Issue 1
Abstract
Aims: There is a need for more biologic research in autistic disorder (AD) to determine if biomarkers exist that would be useful for correlating to symptom severity and/or clinical improvement during treatment. Given the fact that AD is 4 times more common in males than females, gender differences in physiological biomarkers may be present. One potential biomarker that has begun to be studied is brain-derived neurotropic factor (BDNF), a peptide involved in the regulation of neuronal cell survival, differentiation, and plasticity, and possessing an ability to influence neurotransmitter systems by modulating gene expression. This pilot study examined whether serum BDNF differed according to gender in children with AD and whether differences were associated with a behavioral phenotype or severity of illness. Study Design: Data for this investigation were collected during the participants’ baseline visit of an intervention study. Participants were males (n=29) and females (n=7), aged 5 to 12 years diagnosed with AD. Baseline serum BDNF concentration was determined for comparison to clinical ratings using an autism severity measure and the Pervasive Developmental Disorder-Behavior Inventory (PDD-BI). Results: BDNF serum concentrations were higher in females (p<0.049). The baseline BDNF value corresponded significantly to hyperactivity in females (p<0.0002) but not in males. BDNF did not correlate with severity of disease in either gender. Conclusion: Although this is a small study, a better understanding of the central role of BDNF may provide insight into the pathophysiology of the disease and elucidate why gender differences exist in prevalence and behavioral phenotype of AD.
Authors and Affiliations
Eve G. Spratt, Ann-Charlotte Granholm, Laura A. Carpenter, Heather A. Boger, Carrie E. Papa, Sarah Logan, Humera Chaudhary, Sarah-Wade Boatwright, Kathleen T. Brady
Keywords
Related Articles
- EP ID EP241469
- DOI 10.9734/INDJ/2015/12118
- Views 128
- Downloads 0
Neurobehavioral and Micro Structural Evaluation of the Anti-anxiety Potential of Flaxseed oil Following Rotenone-induced Parkinson’ Disease in Mice
Aim: This study investigated the neurobehavioral and micro structural anti-anxiety potential of flaxseed oil following rotenone-induced Parkinson’ disease [PD] in mice Study Design: Fifty-six adult male and female mice (...
Physical Body, Imaginary Body, Symbolic Body: Investigating the Latent Dimensions of Change
Background and Objectives: We present a pilot study of arts psychotherapy proposed in combination with cognitive restructuring techniques to N=13 adult women affected by a disturbed body image, low self-esteem and depres...
Resveratrol Reduces C-reactive Protein and Cholesterol in Schizophrenia
Patients with schizophrenia (SZ) are generally found with overweight and obesity and several metabolic disorders. Additionally these patients have less life expectancy, with cardiovascular disease (CVD) the main cause of...
Striatal Synaptosomal Dopamine and Serotonin Cross-talk Synthesis in Aging Rat
Aims: The existence of a dopamine (DA)-serotonin (5-HT) interaction in the brain has been validated by numerous studies. Nevertheless, interaction between DA- 5-HT synthesis in aging brain has not been highly considered....
Detrimental Effects of Epilepsy and Anti-Epileptic Drugs on Sexual Function and Potency of Epileptic Male Patients
Objectives: To assess effect of epilepsy and anti-epileptic drug (AED) therapy on sexual function and potency of the epileptic male patients. Patients and Methods: This is a cross-sectional study incorporated 40 epilepti...